Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Published Online
on April 8, 2002

Circulation. 2002
Published online before print April 8, 2002, doi: 10.1161/01.CIR.0000015505.24187.FA
A more recent version of this article appeared on April 30, 2002
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
105/17/2058    most recent
01.CIR.0000015505.24187.FAv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mäkikallio, K.
Right arrow Articles by Räsänen, J.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Mäkikallio, K.
Right arrow Articles by Räsänen, J.
Related Collections
Right arrow Other heart failure
Right arrow Echocardiography

Submitted on November 19, 2001
Revised on February 27, 2002
Accepted on February 28, 2002

Ultrasonographic and Biochemical Markers of Human Fetal Cardiac Dysfunction in Placental Insufficiency

Kaarin Mäkikallio MD, Olli Vuolteenaho MD, Pentti Jouppila MD, and Juha Räsänen MD*

From the Departments of Obstetrics and Gynecology (K.M., P.J., J.R.) and Physiology, Biocenter Oulu (O.V.), University of Oulu, Oulu, Finland.

* To whom correspondence should be addressed. E-mail: juharasa{at}cc.oulu.fi.

Background—Placental insufficiency may lead to fetal cardiovascular compromise. We sought to determine whether ultrasonographic parameters of fetal cardiovascular function correlate with umbilical arterial levels of biochemical markers of myocardial dysfunction and damage in placental insufficiency.

Methods and Results—In 48 fetuses with placental insufficiency, umbilical artery blood was obtained at delivery for assessment of N-terminal peptide of proatrial natriuretic peptide (NT-proANP) and cardiac troponin-T (cTnT). Group 1 fetuses (n=12) had normal NT-proANP and cTnT serum concentrations. Group 2 fetuses (n=25) showed increased NT-proANP (>1145 pmol/L) and normal cTnT values. Group 3 fetuses (n=11) had increased NT-proANP and cTnT (>0.10 ng/mL) levels. The ultrasonographic parameters of fetal cardiovascular function were compared between the groups. Pulsatility indices for veins of the ductus venosus, left hepatic vein, and inferior vena cava correlated significantly with NT-proANP levels. In group 3, ductus venosus, left hepatic vein, and inferior vena cava pulsatility indices for veins were higher (P<0.01) than in groups 1 and 2. The proportion of left ventricular cardiac output of combined cardiac output was greater (P<0.05) and that of right ventricle was smaller (P<0.05) in group 3 than in group 2. In group 3, tricuspid regurgitation was noted most often (P<0.05), and right ventricular fractional shortening was less (P<0.01) than in group 2.

Conclusions—Pulsatility in human fetal systemic veins correlated significantly with the cardiac secretion of ANP. Fetuses with myocardial damage demonstrate increased systemic venous pressure, a change in the distribution of cardiac output toward the left ventricle, and a rise in right ventricular afterload.


Key words: echocardiography • troponin • natriuretic peptides • fetal growth retardation • physiology




This article has been cited by other articles:


Home page
CirculationHome page
B. O. Verburg, V. W.V. Jaddoe, J. W. Wladimiroff, A. Hofman, J. C.M. Witteman, and E. A.P. Steegers
Fetal Hemodynamic Adaptive Changes Related to Intrauterine Growth: The Generation R Study
Circulation, February 5, 2008; 117(5): 649 - 659.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
G. Acharya, J. Rasanen, K. Makikallio, T. Erkinaro, T. Kavasmaa, M. Haapsamo, L. Mertens, and J. C. Huhta
Metabolic acidosis decreases fetal myocardial isovolumic velocities in a chronic sheep model of increased placental vascular resistance
Am J Physiol Heart Circ Physiol, January 1, 2008; 294(1): H498 - H504.
[Abstract] [Full Text] [PDF]


Home page
J Ultrasound MedHome page
G. Wong and D. Levine
Fetuses With Trisomy 21 Having Conflicting Findings on Antenatal Testing for Fetal Well-being
J. Ultrasound Med., November 1, 2005; 24(11): 1541 - 1545.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
S. Rounioja, J. Rasanen, M. Ojaniemi, V. Glumoff, H. Autio-Harmainen, and M. Hallman
Mechanism of Acute Fetal Cardiovascular Depression after Maternal Inflammatory Challenge in Mouse
Am. J. Pathol., June 1, 2005; 166(6): 1585 - 1592.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
K Makikallio, P Jouppila, and J Rasanen
Human fetal cardiac function during the first trimester of pregnancy
Heart, March 1, 2005; 91(3): 334 - 338.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
G. Acharya, T. Erkinaro, K. Makikallio, T. Lappalainen, and J. Rasanen
Relationships among Doppler-derived umbilical artery absolute velocities, cardiac function, and placental volume blood flow and resistance in fetal sheep
Am J Physiol Heart Circ Physiol, April 1, 2004; 286(4): H1266 - H1272.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
S. Rounioja, J. Rasanen, V. Glumoff, M. Ojaniemi, K. Makikallio, and M. Hallman
Intra-amniotic lipopolysaccharide leads to fetal cardiac dysfunction: A mouse model for fetal inflammatory response
Cardiovasc Res, October 15, 2003; 60(1): 156 - 164.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. M. Maki, J. Rasanen, H. Tikkanen, R. Sormunen, K. Makikallio, K. I. Kivirikko, and R. Soininen
Inactivation of the Lysyl Oxidase Gene Lox Leads to Aortic Aneurysms, Cardiovascular Dysfunction, and Perinatal Death in Mice
Circulation, November 5, 2002; 106(19): 2503 - 2509.
[Abstract] [Full Text] [PDF]